Omnicell financials
$34.31+1.30%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.18B | $1.11B | $1.15B | $1.30B | $1.13B | $892.2M | $897.0M | $787.3M | $712.7M | $695.9M |
| Gross profit | $503.4M | $471.0M | $496.8M | $589.0M | $554.7M | $413.3M | $436.9M | $372.3M | $318.6M | $317.1M |
| Gross margin | 42.5% | 42.3% | 43.3% | 45.4% | 49.0% | 46.3% | 48.7% | 47.3% | 44.7% | 45.6% |
| Operating income | $5.2M | $337.0K | -$34.9M | -$2.3M | $89.5M | $35.5M | $78.4M | $44.4M | $11.1M | $21.4M |
| Net income | $2.1M | $12.5M | -$20.4M | $5.6M | $77.8M | $32.2M | $61.3M | $37.7M | $30.5M | $9.8M |
| Net margin | 0.2% | 1.1% | −1.8% | 0.4% | 6.9% | 3.6% | 6.8% | 4.8% | 4.3% | 1.4% |
| Diluted EPS | $0.04 | $0.27 | $-0.45 | $0.12 | $1.62 | $0.74 | $1.43 | $0.93 | $0.79 | $0.26 |
| EBITDA | $84.0M | $82.6M | $52.5M | $84.6M | $174.4M | $96.6M | $142.5M | $95.7M | $62.7M | $79.8M |
| Operating cash flow | $127.3M | $187.7M | $181.1M | $77.8M | $231.8M | $185.9M | $145.0M | $104.0M | $24.8M | $50.5M |
| Free cash flow | $86.9M | $151.3M | $139.6M | $17.0M | $202.8M | $163.0M | $129.1M | $80.3M | $9.5M | $37.1M |
| Diluted shares | 46.4M | 46.3M | 45.2M | 45.9M | 47.9M | 43.7M | 42.9M | 40.6M | 38.7M | 36.9M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $196.5M | $369.2M | $468.0M | $330.4M | $349.1M | $485.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $167.6M | $340.7M | $569.7M | $566.6M | $488.2M | $467.2M |
| Total assets | $1.97B | $2.12B | $2.23B | $2.21B | $2.14B | $1.82B |
| Total liabilities | $742.9M | $877.6M | $1.04B | $1.08B | $995.8M | $857.0M |
| Shareholders' equity | $1.23B | $1.24B | $1.19B | $1.13B | $1.15B | $967.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology